GE HealthCare Q1 revenue rises 7.4% but profit falls; 2026 Adjusted EPS outlook cut
GE HealthCare reported first quarter 2026 revenue of $5.1 billion, up 7.4%, but net income attributable to the company fell to $389 million from $564 million and diluted EPS fell to $0.85 from $1.23. The company cut its full-year 2026 Adjusted EPS guidance to $4.80 to $5.00 from $4.95 to $5.15, citing higher memory chip, oil and freight costs, so shareholders face lower expected profit this year even as sales grew.
Key points
- Q1 2026 revenue of $5.1 billion, up 7.4%; organic revenue growth of 2.9%
- Net income attributable to GE HealthCare of $389 million vs. $564 million; Adjusted EPS of $0.99 vs. $1.01
- 2026 Adjusted EPS guidance cut to $4.80 to $5.00 from $4.95 to $5.15; free cash flow guidance cut to about $1.6 billion from about $1.7 billion
- Quarterly dividend declared at $0.035 per share; $100 million of stock repurchased in the quarter
The filing
Written by AI on Nov 8, 2026, 1:30 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 29, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.